✦ LIBER ✦

Treatment Monitoring Program for Implementation of Adherence to Second-Line Erlotinib for Advanced Non–Small-Cell Lung Cancer

✍ Scribed by Gebbia, Vittorio; Bellavia, Massimo; Banna, Giuseppe Luigi; Russo, Paolo; Ferraù, Francesco; Tralongo, Paolo; Borsellino, Nicolò

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

50 IMPLEMENTATION OF ADHERENCE TO ERLOTI

✍ V. Gebbia; G. Bellavia; P. Russo; G.L. Banna; F. Ferraù; P. Tralongo; N. Borsell 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Second-line erlotinib for non-small-cell

✍ Vito Lorusso; Saverio Cinieri 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 70 KB

Second-line erlotinib for non-small-cell

✍ Tudor Ciuleanu 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 35 KB

Second-line therapy for advanced non-sma

✍ Christine L. Hann; Julie R. Brahmer 📂 Article 📅 2006 🏛 Current Science Inc. 🌐 English ⚖ 90 KB

PCN67 Erlotinib as Second Line Treatment

✍ Santos, E.A.V.; Buschinelli, C.T.; Ferracini, M.; Pepe, C.; Estanislao, M. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Second-line treatment for advanced non-s

✍ Barlési, Fabrice; Jacot, William; Astoul, Philippe; Pujol, Jean-Louis 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 158 KB